Kiely BE - Search Results

1

More than just the median: Calculating survival times for patients with HER2 positive, metastatic breast cancer using data from recent randomised trials.

Vasista A, Stockler MR, West T, Wilcken N, Kiely BE. Vasista A, et al. Among authors: kiely be. Breast. 2017 Feb;31:99-104. doi: 10.1016/j.breast.2016.10.007. Epub 2016 Nov 6. Breast. 2017. PMID: 27829202

2

Certain death in uncertain time: informing hope by quantifying a best case scenario.

Kiely BE, Tattersall MH, Stockler MR. Kiely BE, et al. J Clin Oncol. 2010 Jun 1;28(16):2802-4. doi: 10.1200/JCO.2009.27.3326. Epub 2010 Apr 20. J Clin Oncol. 2010. PMID: 20406926 Review. No abstract available.

3

How long have I got? Estimating typical, best-case, and worst-case scenarios for patients starting first-line chemotherapy for metastatic breast cancer: a systematic review of recent randomized trials.

Kiely BE, Soon YY, Tattersall MH, Stockler MR. Kiely BE, et al. J Clin Oncol. 2011 Feb 1;29(4):456-63. doi: 10.1200/JCO.2010.30.2174. Epub 2010 Dec 28. J Clin Oncol. 2011. PMID: 21189397 Review.

4

Life after adjuvant chemotherapy for breast cancer: the news is mostly good.

Kiely BE, Wilcken NR, Stockler MR. Kiely BE, et al. J Clin Oncol. 2011 Mar 20;29(9):1092-3. doi: 10.1200/JCO.2010.33.5588. Epub 2011 Feb 7. J Clin Oncol. 2011. PMID: 21300925 No abstract available.

5

Thinking and talking about life expectancy in incurable cancer.

Kiely BE, Stockler MR, Tattersall MH. Kiely BE, et al. Semin Oncol. 2011 Jun;38(3):380-5. doi: 10.1053/j.seminoncol.2011.03.007. Semin Oncol. 2011. PMID: 21600367

6

ACP Journal Club. Meta-analysis: adjuvant tamoxifen reduces recurrence and death at 15 years in ER-positive early breast cancer.

Kiely B, Stockler M. Kiely B, et al. Ann Intern Med. 2012 Mar 20;156(6):JC3-4. doi: 10.7326/0003-4819-156-6-201203200-02004. Ann Intern Med. 2012. PMID: 22431690 No abstract available.

7

Estimating typical, best-case and worst-case life expectancy scenarios for patients starting chemotherapy for advanced non-small-cell lung cancer: a systematic review of contemporary randomized trials.

Kiely BE, Alam M, Blinman P, Tattersall MH, Stockler MR. Kiely BE, et al. Lung Cancer. 2012 Sep;77(3):537-44. doi: 10.1016/j.lungcan.2012.04.017. Epub 2012 May 18. Lung Cancer. 2012. PMID: 22609149 Review.

8

Incidence of metastatic breast cancer in an Australian population-based cohort of women with non-metastatic breast cancer at diagnosis.

Lord SJ, Marinovich ML, Patterson JA, Wilcken N, Kiely BE, Gebski V, Crossing S, Roder DM, Gattellari M, Houssami N. Lord SJ, et al. Among authors: kiely be. Med J Aust. 2012 Jun 18;196(11):688-92. doi: 10.5694/mja12.10026. Med J Aust. 2012. PMID: 22708766

9

Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience.

Kiely BE, McCaughan G, Christodoulou S, Beale PJ, Grimison P, Trotman J, Tattersall MH, Stockler MR. Kiely BE, et al. Support Care Cancer. 2013 Feb;21(2):369-76. doi: 10.1007/s00520-012-1526-4. Epub 2012 Jun 21. Support Care Cancer. 2013. PMID: 22717918

10

Survival times of women with metastatic breast cancer starting first-line chemotherapy in routine clinical practice versus contemporary randomised trials.

Thientosapol ES, Tran TT, Della-Fiorentina SA, Adams DH, Chantrill L, Stockler MR, Kiely BE. Thientosapol ES, et al. Among authors: kiely be. Intern Med J. 2013 Aug;43(8):883-8. doi: 10.1111/imj.12178. Intern Med J. 2013. PMID: 23656187 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters